The traditional Chinese medical compound Rocaglamide protects nonmalignant primary cells from DNA damage-induced toxicity by inhibition of p53 expression

One of the main obstacles of conventional anticancer therapy is the toxicity of chemotherapeutics to normal tissues. So far, clinical approaches that aim to specifically reduce chemotherapy-mediated toxicities are rare. Recently, a number of studies have demonstrated that herbal extracts derived fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, M S, Schmezer, P, Breuer, R, Haas, S F, Essers, M A, Krammer, P H, Li-Weber, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040689/
https://www.ncbi.nlm.nih.gov/pubmed/24434508
http://dx.doi.org/10.1038/cddis.2013.528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040689/
https://www.ncbi.nlm.nih.gov/pubmed/24434508
http://dx.doi.org/10.1038/cddis.2013.528

Ejemplares similares